ArticleArchives of virology2026
Length and density of α2-3 sialyllactose-containing chains on glycopolymers determine receptor binding of avian influenza viruses.
Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Influenza A viruses use host sialoglycans for attachment via hemagglutinin (HA) and hydrolyze them upon budding via neuraminidase (NA). The HAs of some human isolates prefer extended and branched glycans for binding; however, the preference of avian influenza viruses (AIVs) for these glycans is poorly understood. This study addressed the glycan-binding preferences of HA and AIV particles by using a series of sialoglycopolymers with various glycan representations and densities. Glycan extension was mimicked by linking the terminal sialyllactose with subsequent polyethylene glycol chains, and glycan density was further controlled by polymerizing the glycomonomers with the corresponding numbers of acrylamide spacers. Recombinant HAs and particles of two AIVs were used in a solid-phase direct binding assay with the aforementioned sialoglycopolymers. Both recombinant HAs preferred higher-density glycans, but did not bind to the homopolymer with the highest density. These observations suggested that most sialyllactoses in the highest-density polymer were not involved in the interaction with HA, whereas extremely high-density sialyllactoses negatively impacted HA binding. Additionally, binding analysis using viral particles demonstrated that HA clusters on the particles compensated for weak binding to low-density glycans by employing multivalent HA-glycan interactions. This approach enabled the evaluation of the complex nature of viral particles as macromolecules in glycan binding and the clustering effect of glycan density in a glycopolymer. These findings suggest elaborate protein-carbohydrate interactions via multivalent receptor-ligand binding between AIV particles and sialoglycans.
Indexed as
Identifiers
41741719What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.